The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity.
about
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR PathwayRegulation of Retinoic Acid Inducible Gene-I (RIG-I) Activation by the Histone Deacetylase 6Immune and non-immune responses to hepatitis C virus infectionRegulation of hepatic innate immunity by hepatitis C virusThe tripartite motif coiled-coil is an elongated antiparallel hairpin dimer.Viral Evasion Strategies in Type I IFN Signaling - A Summary of Recent DevelopmentsRIG-I in RNA virus recognitionRIG-I-like receptor regulation in virus infection and immunityInnate immune pattern recognition: a cell biological perspectiveViral evasion of intracellular DNA and RNA sensingHuman genome-wide RNAi screen identifies an essential role for inositol pyrophosphates in Type-I interferon responseProteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle traffickingMechanism of TRIM25 Catalytic Activation in the Antiviral RIG-I Pathway.Cyclophilin A-regulated ubiquitination is critical for RIG-I-mediated antiviral immune responses.A structure-based model of RIG-I activationA distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responsesHepatitis C virus and antiviral innate immunity: who wins at tug-of-war?HSPD1 interacts with IRF3 to facilitate interferon-beta induction.Hepatitis C Virus. Strategies to Evade Antiviral ResponsesActivation and evasion of antiviral innate immunity by hepatitis C virus.14-3-3 in Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel VasculitisCell-intrinsic innate immune control of West Nile virus infection.Emerging roles of interferon-stimulated genes in the innate immune response to hepatitis C virus infectionSignaling organelles of the innate immune system.A phosphomimetic-based mechanism of dengue virus to antagonize innate immunity.Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD.Proteome Response of Chicken Embryo Fibroblast Cells to Recombinant H5N1 Avian Influenza Viruses with Different Neuraminidase Stalk Lengths.Intracellular pathogen detection by RIG-I-like receptors.Recognition of viruses in the cytoplasm by RLRs and other helicases--how conformational changes, mitochondrial dynamics and ubiquitination control innate immune responses.Structural basis of innate immune recognition of viral RNA.Multi-step regulation of interferon induction by hepatitis C virus.West Nile virus infection and immunity.Peroxisomes and the antiviral responses of mammalian cells.The innate immune playbook for restricting West Nile virus infection.MAVS Coordination of Antiviral Innate Immunity.Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity.Links between recognition and degradation of cytoplasmic viral RNA in innate immune response.Photodynamic treatment with hexyl-aminolevulinate mediates reversible thiol oxidation in core oxidative stress signaling proteins.Innate immune evasion strategies of DNA and RNA viruses.Multilayered regulations of RIG-I in the anti-viral signaling pathway.
P2860
Q26700090-0F50607A-98B1-44BC-9C16-2407FBB96A54Q26700093-638CF9C6-E56F-4C63-8125-5BB77B68FB71Q26782040-533AF1ED-345D-4A4E-B1BE-46B8C685B935Q26824743-8F95C469-B5A8-4387-8F2D-76EB62F8F144Q27681792-732677EB-5917-43D2-8065-C30E4946EF25Q28069090-9FF4BF98-18B2-41F1-8E43-2EF184AC8486Q28081618-EDDD8798-42F3-4C47-BB01-F467DD947E27Q28081647-BE3F3E46-0DFA-47C6-BE5A-0BC6D2112FDAQ28255348-5B183167-A8A6-4CE8-BC8E-EBA25B410F9DQ28392078-2F1277D1-DE4D-44BB-9E44-22A2368DCA40Q28540195-B7A0F300-C368-45D6-8715-6E49408E2850Q28543776-B84ADAC6-CF4A-4CA8-81B2-29D0CB4B7BF6Q30276351-3B61F0B5-91DF-41CE-8658-75938597FC74Q33835048-05D6AD0C-6883-4F9C-8073-3BCABD1B5D99Q34464259-047817CA-2ED7-4CC5-8430-3B8349472349Q34945431-53701FF8-E2A6-4740-B242-638D3A25BFB6Q35270150-399D8B0B-EFC7-4B11-89DD-93F12981A7D7Q35519523-C9118959-B66D-47B2-B7B1-8C7F12A32B85Q35604054-51E59F59-E035-4800-B60C-A480397900D8Q35606341-D8BFA196-92C5-44AF-B60C-FF8EED3AEC8BQ36219021-95FB8887-F93D-4BA1-8651-5AD93FFA934FQ36287746-8ABA54CB-58A1-43C7-9F6E-9AB5E836E30BQ36460968-CFEDB0BC-0091-4DF7-9324-6FBECE03764CQ36470941-C8F9BFF1-98D1-4E6F-ADA2-BC8E656E3582Q36813821-A228D586-C4A4-4E06-A510-01B4B67A28B6Q37000243-1AFA16EC-6677-46B4-B96B-776F6D7FD12CQ37581452-D4B69022-41C4-4561-8E81-C251FA8D9663Q37627133-C2200917-A4DF-4C08-825C-7CCE1E504865Q38054048-616D27EF-7B36-4E9A-AA9E-B9B5F5B598B0Q38056521-73137CDA-A613-4E36-B776-D4B5BA296D8FQ38071909-58E9D0EE-9A36-4F41-BA14-1D6F7C528AF2Q38074266-20BD16AD-50A4-480A-8EDC-E8C660043F5FQ38118911-8075E932-E3D1-4534-A039-B6A2CF9D4971Q38157732-66FCBDFA-F407-4DC7-B39A-C8869333E8C2Q38463327-770D9015-0B97-4C5D-B681-2A7B4DDA5E5DQ38495929-6B170C94-A37B-4287-B383-AF2D82AC5957Q38661444-1B2A08A5-5CF7-49F3-948B-84EB9F848815Q38805845-8C457446-14A4-4998-AF39-AEDE8041BE29Q38862108-1F2F35D7-A219-42FC-B179-AF63AFF0966BQ38939998-46AA6399-AA62-4906-905F-37F45380CDF0
P2860
The mitochondrial targeting chaperone 14-3-3ε regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The mitochondrial targeting ch ...... and innate antiviral immunity.
@en
The mitochondrial targeting ch ...... and innate antiviral immunity.
@nl
type
label
The mitochondrial targeting ch ...... and innate antiviral immunity.
@en
The mitochondrial targeting ch ...... and innate antiviral immunity.
@nl
prefLabel
The mitochondrial targeting ch ...... and innate antiviral immunity.
@en
The mitochondrial targeting ch ...... and innate antiviral immunity.
@nl
P2860
P50
P1433
P1476
The mitochondrial targeting ch ...... and innate antiviral immunity
@en
P2093
Gregory A Zornetzer
Yueh-Ming Loo
P2860
P304
P356
10.1016/J.CHOM.2012.04.006
P577
2012-05-01T00:00:00Z